These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 28859548)
1. Recovery of 3-Iodothyronamine and Derivatives in Biological Matrixes: Problems and Pitfalls. Lorenzini L; Ghelardoni S; Saba A; Sacripanti G; Chiellini G; Zucchi R Thyroid; 2017 Oct; 27(10):1323-1331. PubMed ID: 28859548 [TBL] [Abstract][Full Text] [Related]
2. Tissue distribution and cardiac metabolism of 3-iodothyronamine. Saba A; Chiellini G; Frascarelli S; Marchini M; Ghelardoni S; Raffaelli A; Tonacchera M; Vitti P; Scanlan TS; Zucchi R Endocrinology; 2010 Oct; 151(10):5063-73. PubMed ID: 20739399 [TBL] [Abstract][Full Text] [Related]
3. In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine. Laurino A; De Siena G; Saba A; Chiellini G; Landucci E; Zucchi R; Raimondi L Eur J Pharmacol; 2015 Aug; 761():130-4. PubMed ID: 25941083 [TBL] [Abstract][Full Text] [Related]
4. Determination of 3-iodothyronamine (3-T Li ZM; Miller M; Gachkar S; Mittag J; Schriever SC; Pfluger PT; Schramm KW; De Angelis M J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1165():122553. PubMed ID: 33503577 [TBL] [Abstract][Full Text] [Related]
5. Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity. Accorroni A; Rutigliano G; Sabatini M; Frascarelli S; Borsò M; Novelli E; Bandini L; Ghelardoni S; Saba A; Zucchi R; Origlia N Thyroid; 2020 Jan; 30(1):147-160. PubMed ID: 31709926 [No Abstract] [Full Text] [Related]
6. Uptake and metabolic effects of 3-iodothyronamine in hepatocytes. Ghelardoni S; Chiellini G; Frascarelli S; Saba A; Zucchi R J Endocrinol; 2014 Apr; 221(1):101-10. PubMed ID: 24627446 [TBL] [Abstract][Full Text] [Related]
7. Redox Properties of 3-Iodothyronamine (T1AM) and 3-Iodothyroacetic Acid (TA1). Gencarelli M; Lodovici M; Bellusci L; Raimondi L; Laurino A Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269859 [TBL] [Abstract][Full Text] [Related]
8. 3-Iodothyronamine reduces insulin secretion in vitro via a mitochondrial mechanism. Lehmphul I; Hoefig CS; Köhrle J Mol Cell Endocrinol; 2018 Jan; 460():219-228. PubMed ID: 28754352 [TBL] [Abstract][Full Text] [Related]
9. The 3-iodothyronamine (T1AM) and the 3-iodothyroacetic acid (TA1) indicate a novel connection with the histamine system for neuroprotection. Laurino A; Gencarelli M; Raimondi L Eur J Pharmacol; 2021 Dec; 912():174606. PubMed ID: 34717926 [TBL] [Abstract][Full Text] [Related]
10. Delivery of Thyronamines (TAMs) to the Brain: A Preliminary Study. di Leo N; Moscato S; Borso' M; Sestito S; Polini B; Bandini L; Grillone A; Battaglini M; Saba A; Mattii L; Ciofani G; Chiellini G Molecules; 2021 Mar; 26(6):. PubMed ID: 33799468 [TBL] [Abstract][Full Text] [Related]
11. Exogenous 3-Iodothyronamine (T Bandini L; Sacripanti G; Borsò M; Tartaria M; Fogliaro MP; Giannini G; Carnicelli V; Figuccia ME; Verlotta S; De Antoni F; Zucchi R; Ghelardoni S Life (Basel); 2022 Aug; 12(9):. PubMed ID: 36143389 [TBL] [Abstract][Full Text] [Related]
17. The influence of culture media upon observed cell secretome metabolite profiles: The balance between cell viability and data interpretability. Daskalaki E; Pillon NJ; Krook A; Wheelock CE; Checa A Anal Chim Acta; 2018 Dec; 1037():338-350. PubMed ID: 30292310 [TBL] [Abstract][Full Text] [Related]
18. 3-Iodothyronamine and 3,5,3'-triiodo-L-thyronine reduce SIRT1 protein expression in the HepG2 cell line. Sacripanti G; Lorenzini L; Bandini L; Frascarelli S; Zucchi R; Ghelardoni S Horm Mol Biol Clin Investig; 2020 Mar; 41(1):. PubMed ID: 32114521 [TBL] [Abstract][Full Text] [Related]
19. Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway. Rogowski M; Bellusci L; Sabatini M; Rapposelli S; Rahman SM; Chiellini G; Assadi-Porter FM Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31434215 [TBL] [Abstract][Full Text] [Related]
20. The impact of scopolamine pretreatment on 3-iodothyronamine (T1AM) effects on memory and pain in mice. Laurino A; Lucenteforte E; De Siena G; Raimondi L Horm Behav; 2017 Aug; 94():93-96. PubMed ID: 28711308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]